KYTX logo

Kyverna Therapeutics (KYTX) Cash From Investing

Annual CFI

-$8.79 M
+$5.31 M+37.68%

December 31, 2023


Summary


Performance

KYTX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYTXcash flowmetrics:

Quarterly CFI

$676.00 K
+$68.60 M+101.00%

September 30, 2024


Summary


Performance

KYTX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYTXcash flowmetrics:

TTM CFI

-$158.44 M
+$54.79 M+25.70%

September 30, 2024


Summary


Performance

KYTX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYTXcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

KYTX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+37.7%-97.9%-1703.6%
3 y3 years-581.5%-97.9%-1703.6%
5 y5 years-581.5%-97.9%-1703.6%

KYTX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-581.5%+37.7%-97.9%+100.5%-1260.3%+25.7%
5 y5-year-581.5%+37.7%-97.9%+100.5%-1260.3%+25.7%
alltimeall time-581.5%+37.7%-97.9%+100.5%-1260.3%+25.7%

Kyverna Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$676.00 K(-101.0%)
-$158.44 M(-25.7%)
Jun 2024
-
-$67.92 M(-44.7%)
-$213.24 M(+46.7%)
Mar 2024
-
-$122.88 M(-487.9%)
-$145.32 M(+1554.2%)
Dec 2023
-$8.79 M
$31.68 M(-158.5%)
-$8.79 M(-78.3%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$54.12 M(>+9900.0%)
-$40.47 M(-396.4%)
Jun 2023
-
-$3000.00(-100.0%)
$13.65 M(-0.0%)
Mar 2023
-
$13.65 M
$13.65 M
Dec 2022
-$14.10 M(+993.6%)
-
-
Dec 2021
-$1.29 M
-
-

FAQ

  • What is Kyverna Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Kyverna Therapeutics?
  • What is Kyverna Therapeutics annual CFI year-on-year change?
  • What is Kyverna Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Kyverna Therapeutics?
  • What is Kyverna Therapeutics quarterly CFI year-on-year change?
  • What is Kyverna Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Kyverna Therapeutics?
  • What is Kyverna Therapeutics TTM CFI year-on-year change?

What is Kyverna Therapeutics annual cash flow from investing activities?

The current annual CFI of KYTX is -$8.79 M

What is the all time high annual CFI for Kyverna Therapeutics?

Kyverna Therapeutics all-time high annual cash flow from investing activities is -$1.29 M

What is Kyverna Therapeutics annual CFI year-on-year change?

Over the past year, KYTX annual cash flow from investing activities has changed by +$5.31 M (+37.68%)

What is Kyverna Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of KYTX is $676.00 K

What is the all time high quarterly CFI for Kyverna Therapeutics?

Kyverna Therapeutics all-time high quarterly cash flow from investing activities is $31.68 M

What is Kyverna Therapeutics quarterly CFI year-on-year change?

Over the past year, KYTX quarterly cash flow from investing activities has changed by -$31.00 M (-97.87%)

What is Kyverna Therapeutics TTM cash flow from investing activities?

The current TTM CFI of KYTX is -$158.44 M

What is the all time high TTM CFI for Kyverna Therapeutics?

Kyverna Therapeutics all-time high TTM cash flow from investing activities is $13.65 M

What is Kyverna Therapeutics TTM CFI year-on-year change?

Over the past year, KYTX TTM cash flow from investing activities has changed by -$149.66 M (-1703.56%)